BeiGene End Period Cash Flow vs Free Cash Flow Analysis

688235 Stock

228.29 7.41 3.35%

BeiGene financial indicator trend analysis is way more than just evaluating BeiGene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BeiGene is a good investment. Please check the relationship between BeiGene End Period Cash Flow and its Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

End Period Cash Flow vs Free Cash Flow

End Period Cash Flow vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BeiGene End Period Cash Flow account and Free Cash Flow. At this time, the significance of the direction appears to have pay attention.

The correlation between BeiGene's End Period Cash Flow and Free Cash Flow is -0.93. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of BeiGene, assuming nothing else is changed. The correlation between historical values of BeiGene's End Period Cash Flow and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of BeiGene are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of End Period Cash Flow i.e., BeiGene's End Period Cash Flow and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.93

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

End Period Cash Flow

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from BeiGene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 67.5 M, whereas Selling General Administrative is forecasted to decline to about 1 B.

	2022	2023	2024	2025 (projected)
Total Operating Expenses	3.2B	3.7B	4.2B	2.8B
Cost Of Revenue	286.5M	379.9M	341.9M	304.1M

Total Operating Expenses Cost Of Revenue

BeiGene fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital	Intangible Assets	Other Current Liab	Property Plant And Equipment Net	Long Term Investments
Total Assets		0.95	1.0	-0.87	0.92	0.96	0.8	0.98	-0.88	0.86	-0.42	0.96	0.41	0.93	0.94	0.82	0.98	1.0	0.99	0.96	-0.72	0.95	0.87	-0.63	0.71	0.91
Total Current Liabilities	0.95		0.91	-0.95	0.99	0.95	0.95	0.93	-0.89	0.88	-0.46	0.99	0.18	0.77	0.83	0.92	0.99	0.94	0.9	0.99	-0.86	0.8	0.96	-0.83	0.9	0.94
Total Stockholder Equity	1.0	0.91		-0.83	0.89	0.94	0.73	0.97	-0.86	0.83	-0.39	0.92	0.47	0.95	0.95	0.78	0.95	1.0	1.0	0.93	-0.66	0.98	0.83	-0.55	0.64	0.88
Retained Earnings	-0.87	-0.95	-0.83		-0.96	-0.91	-0.93	-0.86	0.87	-0.79	0.57	-0.95	0.02	-0.65	-0.79	-0.97	-0.93	-0.86	-0.81	-0.95	0.93	-0.71	-0.93	0.86	-0.91	-0.93
Accounts Payable	0.92	0.99	0.89	-0.96		0.93	0.96	0.93	-0.9	0.83	-0.49	0.99	0.15	0.73	0.8	0.93	0.98	0.92	0.87	0.99	-0.88	0.77	0.94	-0.84	0.91	0.92
Cash	0.96	0.95	0.94	-0.91	0.93		0.85	0.89	-0.79	0.9	-0.41	0.94	0.18	0.81	0.95	0.86	0.95	0.95	0.93	0.94	-0.85	0.87	0.94	-0.69	0.79	0.98
Non Current Assets Total	0.8	0.95	0.73	-0.93	0.96	0.85		0.78	-0.79	0.83	-0.47	0.93	-0.1	0.53	0.66	0.93	0.91	0.78	0.71	0.92	-0.94	0.57	0.96	-0.94	0.99	0.9
Non Currrent Assets Other	0.98	0.93	0.97	-0.86	0.93	0.89	0.78		-0.93	0.75	-0.42	0.95	0.48	0.91	0.87	0.8	0.96	0.97	0.97	0.95	-0.67	0.92	0.81	-0.62	0.69	0.83
Long Term Debt	-0.88	-0.89	-0.86	0.87	-0.9	-0.79	-0.79	-0.93		-0.69	0.7	-0.92	-0.29	-0.81	-0.74	-0.88	-0.9	-0.88	-0.86	-0.92	0.67	-0.79	-0.77	0.74	-0.73	-0.78
Net Receivables	0.86	0.88	0.83	-0.79	0.83	0.9	0.83	0.75	-0.69		-0.39	0.84	0.08	0.72	0.81	0.82	0.89	0.85	0.82	0.85	-0.78	0.74	0.94	-0.75	0.79	0.93
Good Will	-0.42	-0.46	-0.39	0.57	-0.49	-0.41	-0.47	-0.42	0.7	-0.39		-0.51	0.26	-0.37	-0.42	-0.72	-0.46	-0.41	-0.38	-0.51	0.51	-0.33	-0.48	0.62	-0.51	-0.52
Common Stock Shares Outstanding	0.96	0.99	0.92	-0.95	0.99	0.94	0.93	0.95	-0.92	0.84	-0.51		0.21	0.8	0.85	0.92	0.99	0.95	0.91	1.0	-0.85	0.83	0.94	-0.8	0.87	0.93
Short Term Investments	0.41	0.18	0.47	0.02	0.15	0.18	-0.1	0.48	-0.29	0.08	0.26	0.21		0.65	0.33	-0.12	0.27	0.43	0.5	0.22	0.31	0.6	-0.04	0.3	-0.24	0.01
Non Current Liabilities Total	0.93	0.77	0.95	-0.65	0.73	0.81	0.53	0.91	-0.81	0.72	-0.37	0.8	0.65		0.89	0.62	0.84	0.93	0.96	0.8	-0.42	0.99	0.64	-0.36	0.41	0.72
Capital Lease Obligations	0.94	0.83	0.95	-0.79	0.8	0.95	0.66	0.87	-0.74	0.81	-0.42	0.85	0.33	0.89		0.74	0.87	0.94	0.95	0.85	-0.69	0.94	0.81	-0.47	0.58	0.9
Inventory	0.82	0.92	0.78	-0.97	0.93	0.86	0.93	0.8	-0.88	0.82	-0.72	0.92	-0.12	0.62	0.74		0.9	0.81	0.76	0.92	-0.92	0.65	0.93	-0.92	0.92	0.92
Total Liab	0.98	0.99	0.95	-0.93	0.98	0.95	0.91	0.96	-0.9	0.89	-0.46	0.99	0.27	0.84	0.87	0.9		0.97	0.94	0.99	-0.81	0.86	0.94	-0.77	0.84	0.93
Net Invested Capital	1.0	0.94	1.0	-0.86	0.92	0.95	0.78	0.97	-0.88	0.85	-0.41	0.95	0.43	0.93	0.94	0.81	0.97		0.99	0.95	-0.7	0.96	0.86	-0.61	0.69	0.9
Total Current Assets	0.99	0.9	1.0	-0.81	0.87	0.93	0.71	0.97	-0.86	0.82	-0.38	0.91	0.5	0.96	0.95	0.76	0.94	0.99		0.91	-0.63	0.98	0.81	-0.53	0.61	0.86
Capital Stock	0.96	0.99	0.93	-0.95	0.99	0.94	0.92	0.95	-0.92	0.85	-0.51	1.0	0.22	0.8	0.85	0.92	0.99	0.95	0.91		-0.85	0.83	0.94	-0.8	0.87	0.93
Non Current Liabilities Other	-0.72	-0.86	-0.66	0.93	-0.88	-0.85	-0.94	-0.67	0.67	-0.78	0.51	-0.85	0.31	-0.42	-0.69	-0.92	-0.81	-0.7	-0.63	-0.85		-0.5	-0.94	0.89	-0.95	-0.91
Net Working Capital	0.95	0.8	0.98	-0.71	0.77	0.87	0.57	0.92	-0.79	0.74	-0.33	0.83	0.6	0.99	0.94	0.65	0.86	0.96	0.98	0.83	-0.5		0.69	-0.38	0.46	0.78
Intangible Assets	0.87	0.96	0.83	-0.93	0.94	0.94	0.96	0.81	-0.77	0.94	-0.48	0.94	-0.04	0.64	0.81	0.93	0.94	0.86	0.81	0.94	-0.94	0.69		-0.87	0.94	0.98
Other Current Liab	-0.63	-0.83	-0.55	0.86	-0.84	-0.69	-0.94	-0.62	0.74	-0.75	0.62	-0.8	0.3	-0.36	-0.47	-0.92	-0.77	-0.61	-0.53	-0.8	0.89	-0.38	-0.87		-0.97	-0.79
Property Plant And Equipment Net	0.71	0.9	0.64	-0.91	0.91	0.79	0.99	0.69	-0.73	0.79	-0.51	0.87	-0.24	0.41	0.58	0.92	0.84	0.69	0.61	0.87	-0.95	0.46	0.94	-0.97		0.86
Long Term Investments	0.91	0.94	0.88	-0.93	0.92	0.98	0.9	0.83	-0.78	0.93	-0.52	0.93	0.01	0.72	0.9	0.92	0.93	0.9	0.86	0.93	-0.91	0.78	0.98	-0.79	0.86

Click cells to compare fundamentals

BeiGene Account Relationship Matchups

BeiGene fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	5.6B	8.5B	6.4B	5.8B	6.7B	6.1B
Total Current Liabilities	1.1B	1.6B	1.5B	1.8B	2.1B	1.4B
Total Stockholder Equity	3.9B	6.1B	4.4B	3.5B	4.1B	4.2B
Retained Earnings	(3.6B)	(5.1B)	(7.1B)	(8.0B)	(7.2B)	(7.5B)
Accounts Payable	232.0M	262.4M	294.8M	315.1M	362.4M	269.9M
Cash	1.4B	4.4B	3.9B	3.2B	3.6B	3.0B
Non Current Assets Total	640.1M	921.6M	1.2B	1.6B	1.8B	1.1B
Non Currrent Assets Other	13.7M	13.5M	12.4M	10.9M	12.5M	11.7M
Long Term Debt	183.6M	202.1M	209.1M	197.6M	177.9M	165.3M
Net Receivables	60.4M	483.1M	173.2M	358.0M	411.7M	252.0M
Common Stock Shares Outstanding	1.2B	1.3B	1.4B	1.4B	1.6B	1.3B
Short Term Investments	3.3B	2.2B	665.3M	2.6M	2.3M	2.2M
Non Current Liabilities Total	656.3M	803.4M	527.4M	457.8M	526.5M	614.4M
Capital Lease Obligations	43.3M	65.0M	58.6M	44.2M	50.8M	54.5M
Inventory	89.3M	242.6M	282.3M	416.1M	478.5M	502.5M
Total Liab	1.7B	2.4B	2.0B	2.3B	2.6B	2.0B
Net Invested Capital	4.4B	6.8B	4.9B	4.4B	5.1B	4.8B
Total Current Assets	5.0B	7.6B	5.2B	4.2B	4.8B	5.1B
Non Current Liabilities Other	375.2M	269.6M	179.8M	170.8M	153.8M	212.4M
Net Working Capital	3.9B	6.0B	3.7B	2.4B	2.8B	3.7B
Intangible Assets	53.7M	103.3M	94.6M	108.9M	125.2M	90.9M

Currently Active Assets on Macroaxis

CRM	Salesforce
C	Citigroup
GM	General Motors
WD	Walker Dunlop
MSFT	Microsoft

Other Information on Investing in BeiGene Stock

Balance Sheet is a snapshot of the financial position of BeiGene at a specified time, usually calculated after every quarter, six months, or one year. BeiGene Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of BeiGene and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which BeiGene currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BeiGene End Period Cash Flow vs Free Cash Flow Analysis

End Period Cash Flow vs Free Cash Flow

End Period Cash Flow vs Free Cash Flow Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Free Cash Flow

BeiGene fundamental ratios Correlations

BeiGene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BeiGene fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in BeiGene Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity
Capital Stock	+ 1.0	Common Stock Shares Outstanding
Total Current Assets	+ 0.99	Total Assets

Property Plant And Equipment Net	- 0.97	Other Current Liab
Inventory	- 0.97	Retained Earnings
Accounts Payable	- 0.96	Retained Earnings
Property Plant And Equipment Net	- 0.95	Non Current Liabilities Other
Capital Stock	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings